{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T03:21:54Z","timestamp":1783826514239,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jchf.2022.10.004","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T04:42:39Z","timestamp":1667623359000},"page":"106-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Potential Interactions When Prescribing SGLT2 Inhibitors and Intravenous Iron in\u00a0Combination in Heart\u00a0Failure"],"prefix":"10.1016","volume":"11","author":[{"given":"Milton","family":"Packer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2022.10.004_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.jchf.2022.10.004_bib2","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/CIRCULATIONAHA.122.060511","article-title":"Iron deficiency in heart failure and effect of dapagliflozin: findings from DAPA-HF","volume":"146","author":"Docherty","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2022.10.004_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ejhf.823","article-title":"Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta- analysis","volume":"20","author":"Anker","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2022.10.004_bib4","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2022.10.004_bib5","doi-asserted-by":"crossref","first-page":"10775","DOI":"10.1073\/pnas.0912925107","article-title":"Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol","volume":"107","author":"Richardson","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jchf.2022.10.004_bib6","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.bbagen.2018.09.005","article-title":"Detection and quantitation of iron in ferritin, transferrin and labile iron pool (LIP) in cardiomyocytes using 55Fe and storage phosphorimaging","volume":"1862","author":"Krijt","year":"2018","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.jchf.2022.10.004_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2022.10.004_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12011-017-1003-5","article-title":"Serum hepcidin and soluble transferrin receptor in the assessment of iron metabolism in children on a vegetarian diet","volume":"180","author":"Ambroszkiewicz","year":"2017","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.jchf.2022.10.004_bib9","first-page":"396","article-title":"Utility of access soluble transferrin receptor (sTfR) and sTfR\/log ferritin index in diagnosing iron deficiency anemia","volume":"45","author":"Shin","year":"2015","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.jchf.2022.10.004_bib10","doi-asserted-by":"crossref","first-page":"R330","DOI":"10.1152\/ajpregu.00410.2014","article-title":"Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly","volume":"308","author":"Gammella","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jchf.2022.10.004_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151601","article-title":"Associations among erythroferrone and biomarkers of erythropoiesis and iron metabolism, and treatment with long-term erythropoiesis- stimulating agents in patients on hemodialysis","volume":"11","author":"Honda","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2022.10.004_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.795214","article-title":"Efficacy and safety of vadadustat for anemia in patients with chronic kidney disease: a systematic review and meta- analysis","volume":"12","author":"Xiong","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jchf.2022.10.004_bib13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/1744-9987.12322","article-title":"Effects of long-term erythropoiesis-stimulating agents on iron metabolism in patients on hemodialysis","volume":"19","author":"Onuma","year":"2015","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jchf.2022.10.004_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004431","article-title":"Hyporesponsiveness to darbepoetin alfa in patients with heart failure and anemia in the RED-HF study (Reduction of Events by Darbepoetin Alfa in Heart\u00a0Failure): clinical and prognostic associations","volume":"11","author":"van der Meer","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2022.10.004_bib15","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000380972","article-title":"Erythropoiesis-stimulating agent hyporesponsiveness in end- stage renal disease patients","volume":"185","author":"Ogawa","year":"2015","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jchf.2022.10.004_bib16","first-page":"4744","article-title":"Ferric carboxymaltose and erythropoiesis- stimulating agent treatment reduces the rate of blood transfusion in refractory anemia","volume":"11","author":"Gidaro","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jchf.2022.10.004_bib17","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/j.1523-1755.2005.00758.x","article-title":"A\u00a0randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis- dependent CKD","volume":"68","author":"Van Wyck","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.jchf.2022.10.004_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000080452","article-title":"Darbepoetin alfa effectively treats anemia in patients with chronic kidney disease with de novo every-other-week administration","volume":"24","author":"Toto","year":"2004","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.jchf.2022.10.004_bib19","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood-2002-10-3235","article-title":"Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein","volume":"101","author":"Nemeth","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jchf.2022.10.004_bib20","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1073\/pnas.88.11.4946","article-title":"Iron-independent induction of ferritin H chain by tumor necrosis factor","volume":"88","author":"Miller","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jchf.2022.10.004_bib21","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1042\/BCJ20190017","article-title":"An ion for an iron: streptococcal metal homeostasis under oxidative stress","volume":"476","author":"Jakubovics","year":"2019","journal-title":"Biochem J"},{"key":"10.1016\/j.jchf.2022.10.004_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ajh.23354","article-title":"Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia","volume":"88","author":"Bregman","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jchf.2022.10.004_bib23","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/cid\/ciu945","article-title":"Complex anemia in tuberculosis: the need to consider causes and timing when designing interventions","volume":"60","author":"Minchella","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jchf.2022.10.004_bib24","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa057","article-title":"Dapagliflozin suppresses hepcidin and increases erythropoiesis","volume":"105","author":"Ghanim","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jchf.2022.10.004_bib25","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1111\/dom.14517","article-title":"Effects of empagliflozin on erythropoiesis in patients with type 2 diabetes: data from a randomized, placebo-controlled study","volume":"23","author":"Thiele","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jchf.2022.10.004_bib26","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.2337\/dc20-0456","article-title":"Mechanisms of sodium-glucose cotransporter 2 inhibition: insights from large-scale proteomics","volume":"43","author":"Ferrannini","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2022.10.004_bib27","doi-asserted-by":"crossref","unstructured":"Zannad F, Ferreira JP, Butler J, et\u00a0al. Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights from the EMPEROR program. Eur Heart J. Published online August 26, 2022. https:\/\/doi.org\/10.1093\/eurheartj\/ehac495","DOI":"10.1093\/eurheartj\/ehac495"},{"key":"10.1016\/j.jchf.2022.10.004_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007197","article-title":"Cardioprotective effects of sirtuin-1 and its downstream effectors: potential role in mediating the heart failure benefits of SGLT2 (sodium-glucose cotransporter 2) inhibitors","volume":"13","author":"Packer","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2022.10.004_bib29","doi-asserted-by":"crossref","first-page":"30800","DOI":"10.1074\/jbc.M111.244780","article-title":"The acetylase\/deacetylase couple CREB-binding protein\/Sirtuin 1 controls hypoxia- inducible factor 2 signaling","volume":"287","author":"Chen","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jchf.2022.10.004_bib30","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1042\/CS20190863","article-title":"Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats","volume":"133","author":"Swe","year":"2019","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jchf.2022.10.004_bib31","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.18632\/aging.101954","article-title":"Phloretin protects against cardiac damage and remodeling via restoring SIRT1 and anti-inflammatory effects in the streptozotocin-induced diabetic mouse model","volume":"11","author":"Ying","year":"2019","journal-title":"Aging (Albany, NY)"},{"key":"10.1016\/j.jchf.2022.10.004_bib32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/ars.2015.6315","article-title":"Hydrogen sulfide attenuates inflammatory hepcidin by reducing IL-6 secretion and promoting SIRT1-mediated STAT3 deacetylation","volume":"24","author":"Xin","year":"2016","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jchf.2022.10.004_bib33","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1080\/15548627.2019.1659612","article-title":"SQSTM1\/p62 and PPARGC1A\/PGC-1alpha at the interface of autophagy and vascular senescence","volume":"16","author":"Salazar","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.jchf.2022.10.004_bib34","first-page":"2691","article-title":"NCOA4 is regulated by HIF and mediates mobilization of murine hepatic iron stores after blood loss","volume":"136","author":"Li","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jchf.2022.10.004_bib35","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/eurheartj\/ehi388","article-title":"Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure","volume":"26","author":"Opasich","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2022.10.004_bib36","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.3389\/fimmu.2019.02315","article-title":"Immunity, inflammation and heart failure: their role on cardiac function and iron status","volume":"10","author":"Perticone","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jchf.2022.10.004_bib37","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.clinbiochem.2012.05.011","article-title":"Soluble TNF\u03b1 receptor type I and hepcidin as determinants of development of anemia in the long-term follow-up of heart failure patients","volume":"45","author":"Mart\u00ednez-Ruiz","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jchf.2022.10.004_bib38","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ejhf.1482","article-title":"The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study","volume":"21","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2022.10.004_bib39","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/eurheartj\/ehs377","article-title":"Iron status in patients with chronic heart failure","volume":"34","author":"Jankowska","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2022.10.004_bib40","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacc.2021.11.039","article-title":"Criteria for iron deficiency in patients with heart failure","volume":"79","author":"Masini","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2022.10.004_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004519","article-title":"Definition of iron deficiency based on the gold standard of bone marrow iron staining in heart failure patients","volume":"11","author":"Grote Beverborg","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2022.10.004_bib42","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2006.08.034","article-title":"Etiology of anemia in patients with advanced heart failure","volume":"48","author":"Nanas","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2022.10.004_bib43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/bjh.12311","article-title":"British Committee for Standards in Haematology. Guideline for the laboratory diagnosis of functional iron deficiency","volume":"161","author":"Thomas","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jchf.2022.10.004_bib44","first-page":"389","article-title":"Predictive value of absent bone marrow iron stores in the clinical diagnosis of iron deficiency anemia","volume":"17","author":"Ganti","year":"2003","journal-title":"Vivo"},{"key":"10.1016\/j.jchf.2022.10.004_bib45","first-page":"362","article-title":"Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure","volume":"38","author":"Haddad","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2022.10.004_bib46","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ejhf.1154","article-title":"Iron deficiency impairs contractility of human cardiomyocytes through decreased mitochondrial function","volume":"20","author":"Hoes","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2022.10.004_bib47","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ejhf.2454","article-title":"Cardiac energetics in patients with chronic heart failure and iron deficiency: an in-vivo 31\u00a0P magnetic resonance spectroscopy study","volume":"24","author":"Papalia","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2022.10.004_bib48","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ejhf.2132","article-title":"DAPA-HF Investigators and Committees. Effect of dapagliflozin on anaemia in DAPA-HF","volume":"23","author":"Docherty","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2022.10.004_bib49","first-page":"800","article-title":"Iron overload via heme degradation in the endoplasmic reticulum triggers ferroptosis in myocardial ischemia-reperfusion injury","volume":"7","author":"Miyamoto","year":"2022","journal-title":"J\u00a0Am Coll Cardiol Basic Trans Science"},{"key":"10.1016\/j.jchf.2022.10.004_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.yjmcc.2020.10.010","article-title":"HSF1 functions as a key defender against palmitic acid-induced ferroptosis in cardiomyocytes","volume":"150","author":"Wang","year":"2021","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jchf.2022.10.004_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102021","article-title":"Elucidating the contribution of mitochondrial glutathione to ferroptosis in cardiomyocytes","volume":"45","author":"Jang","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.jchf.2022.10.004_bib52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/physiolgenomics.00079.2021","article-title":"Nrf2 signaling in heart failure: expression of Nrf2, Keap1, antioxidant, and detoxification genes in dilated or ischemic cardiomyopathy","volume":"54","author":"Lu","year":"2022","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.jchf.2022.10.004_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132747","article-title":"Mitochondria- dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity","volume":"5","author":"Tadokoro","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jchf.2022.10.004_bib54","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00210-020-01932-z","article-title":"Ferroptosis occurs in phase of reperfusion but not ischemia in rat heart following ischemia or ischemia\/reperfusion","volume":"394","author":"Tang","year":"2021","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jchf.2022.10.004_bib55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.freeradbiomed.2014.06.019","article-title":"Comparison of various iron chelators and prochelators as protective agents against cardiomyocyte oxidative injury","volume":"74","author":"Jansov\u00e1","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jchf.2022.10.004_bib56","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","article-title":"Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis","volume":"127","author":"Fang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2022.10.004_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113279","article-title":"Ferroptosis and its role in cardiomyopathy","volume":"153","author":"Li","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jchf.2022.10.004_bib58","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jchf.2022.10.004_bib59","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3390\/cells11091399","article-title":"The role of ferroptosis in adverse left ventricular remodeling following acute myocardial infarction","volume":"11","author":"Komai","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jchf.2022.10.004_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111872","article-title":"Ferritinophagy and ferroptosis in cardiovascular disease: mechanisms and potential applications","volume":"141","author":"Qin","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jchf.2022.10.004_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.827559","article-title":"Identification and validation of ferroptosis-related biomarkers in septic cardiomyopathy via bioinformatics analysis","volume":"13","author":"Gong","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.jchf.2022.10.004_bib62","first-page":"1814","article-title":"The SGLT2 inhibitor empagliflozin ameliorates the inflammatory profile in type 2 diabetic patients and promotes an antioxidant response in leukocytes","volume":"8","author":"Iannantuoni","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jchf.2022.10.004_bib63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/DDDT.S269029","article-title":"Roflumilast attenuates doxorubicin-induced cardiotoxicity by targeting inflammation and cellular senescence in cardiomyocytes mediated by SIRT1","volume":"15","author":"Zhang","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jchf.2022.10.004_bib64","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","article-title":"The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin","volume":"20","author":"Quagliariello","year":"2021","journal-title":"Cardiovasc Diabetol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177922006011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177922006011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:02:24Z","timestamp":1761973344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177922006011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213177922006011"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2022.10.004","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential Interactions When Prescribing SGLT2 Inhibitors and Intravenous Iron in\u00a0Combination in Heart\u00a0Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2022.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}